Sewell, NJNCT07184775Now EnrollingIRB Ready

Type 2 Diabetes Mellitus (T2DM) Clinical Trial in Sewell, NJ

Access cutting-edge type 2 diabetes mellitus (t2dm) treatment through this clinical trial at a research site in Sewell. Study-provided care at no cost to qualified participants.

Sponsored by Thomas Jefferson University

Quick Self-Assessment

See if you qualify for this Sewell location

Preparing your pre-screening questions…

Expert Care in Sewell

Access type 2 diabetes mellitus (t2dm) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related type 2 diabetes mellitus (t2dm) treatment provided free

Apply for This Sewell Location

Check if you qualify for this type 2 diabetes mellitus (t2dm) clinical trial in Sewell, NJ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Sewell

    Convenient for NJ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Sewell site if eligible
  4. 4Begin participation

About This Type 2 Diabetes Mellitus (T2DM) Study in Sewell

The purpose of this study is to compare patient adherence to blood sugar monitoring during pregnancy using two different measurement methods in pregnancies complicated by pregestational type 2 diabetes (T2DM). Pregnant patients with T2DM are at risk of having larger babies, babies with low sugar levels in the first 24 hours of life, higher rates of cesarean delivery, stillbirth (death of baby inside the womb), and hypertensive or high blood pressure disorders of pregnancy, such as preeclampsia. Prior studies have shown that treating high blood sugars in pregnancy with medications can reduce these risks. To determine the amount of medication needed, recording of blood sugar levels is necessary. This trial aims to determine whether continuous blood sugar monitors have improved patient recording of blood sugar levels over finger stick blood sugar measurements. Patients involved in the study will be assigned to either: 1. Fingerstick glucose monitoring (FSG) 2. Continuous glucose monitoring (CGM) Patients will be randomize in a 1:1 ratio. FSG Group: blood sugar is tested four times daily - once fasting and two hours after every meal (post-prandial). Blood will be tested using a glucometer, and values will be recorded in a blood sugar log from the time of enrollment to the time of delivery. CGM Group: A CGM sensor will be placed on the patient's arm for blood sugar collection every 3-5 minutes. This data is sent to a phone application from the time of enrollment to the time of delivery. These sensors will need to be replaced every 14 days. Percent adherence will be recorded from the time you were randomized to a study group until delivery.

Sponsor: Thomas Jefferson University

Who Can Participate

Inclusion Criteria

singleton pregnancies
fetuses without anomalies
diagnosis of Type 2 diabetes
initiation of prenatal care at \<20 weeks gestation

Exclusion Criteria

diagnosis of Type 1 diabetes
allergy to insulin
inability to wear a continuous glucose monitor

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Sewell?

Yes, this clinical trial (NCT07184775) has an active research site in Sewell, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Type 2 Diabetes Mellitus (T2DM) Treatment Options in Sewell, NJ

If you're searching for type 2 diabetes mellitus (t2dm) treatment options in Sewell, NJ, this clinical trial (NCT07184775) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Sewell research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 2 diabetes mellitus (t2dm) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all type 2 diabetes mellitus (t2dm) clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Sewell, NJ

See all pulmonary embolism clinical trials recruiting in Sewell — not just this study.

Browse Pulmonary Embolism Trials in Sewell

Ready to Join in Sewell?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Sewell, NJ